Search results
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 6 hours agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
Recent FDA committee vote could speed multiple myeloma drug approval
Medical Xpress· 5 days agoThis Landgren-led study, published May 20 in the journal Blood, featured a meta-analysis of a dozen...
Q&A: Quadruple therapies and the future of multiple myeloma treatment
Medical Xpress· 3 days ago"These are great improvements for patients, and they deliver deep responses," said Landgren, chief...
Mississippi author Greg Iles to host rare reading, book launch Tuesday in Jackson
The Meridian Star· 1 day agoBeneath the heading “medical announcement,” Iles wrote a letter to his readers to let them know that...
Missouri residents affected by radiation exposure push Congress to extend benefits
South Carolina Daily Gazette via Yahoo News· 7 hours agoWASHINGTON — A fund to compensate Americans sickened by exposure to atomic bomb tests, uranium...
New therapy proven effective against rejection in kidney transplantation
Medical Xpress· 6 hours agoThe results were recently published in the New England Journal of Medicine. The research involved 22 patients who were diagnosed with antibody-mediated rejection (AMR) following ...
AI Tool Shows Promise in Cancer Therapy Matching, but More Training Data Needed
GenomeWeb News· 6 days agoA machine learning-based approach could enable the use of computationally intensive single-cell transcriptomic analysis to predict cancer patients' responses to treatment if researchers can ...
Hannah Norman, KFF Health News
The Raw Story· 17 minutes agoAs a young GI at Fort Ord in Monterey County, California, Dean Osborn spent much of his time in the oceanside woodlands, training on soil and guzzling water from streams and aquifers now known ...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 5 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 3 days agoBioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing...
